世界の全身抗生物質市場2020年:企業別、地域別、種類・用途別

【英語タイトル】Global Systemic Antibiotics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP03940)・商品コード:GIR20SP03940
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月18日(※2024年版があります。お問い合わせください)
・ページ数:102
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、全身抗生物質の世界市場を広く調査・分析し、今後の市場展望をまとめております。全身抗生物質の種類別市場規模(βラクタム・βラクタマーゼ阻害剤、キノロン、マクロライド、その他)、用途別市場規模(病院、専門クリニック、在宅介護、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Bausch Health、Novartis、Sun Pharmaceutical Industries、Teva Pharmaceutical Industries、Mylan、Dr. Reddy's Laboratories、Aurobindo Pharma、Pfizer、Amneal Pharmaceuticals、Hikma Pharmaceuticals、Allergan、GlaxoSmithKline
・地域別グローバル市場分析 2015年-2020年
・全身抗生物質の北米市場(アメリカ、カナダ、メキシコ)
・全身抗生物質のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・全身抗生物質のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・全身抗生物質の南米市場(ブラジル、アルゼンチン)
・全身抗生物質の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:βラクタム・βラクタマーゼ阻害剤、キノロン、マクロライド、その他
・用途別分析:病院、専門クリニック、在宅介護、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Systemic Antibiotics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Systemic Antibiotics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Systemic Antibiotics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Systemic Antibiotics market has been segmented into:
β Lactam & β lactamase Inhibitors
Quinolone
Macrolide
Others

By Application, Systemic Antibiotics has been segmented into:
Hospital
Specialty Clinic
Homecare
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Systemic Antibiotics market presented in the report. This section sheds light on the sales growth of different regional and country-level Systemic Antibiotics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Systemic Antibiotics market.

The report offers in-depth assessment of the growth and other aspects of the Systemic Antibiotics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Systemic Antibiotics Market Share Analysis
Systemic Antibiotics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Systemic Antibiotics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Systemic Antibiotics sales, revenue and market share for each player covered in this report.

The major players covered in Systemic Antibiotics are:
Bausch Health
Novartis
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
Mylan
Dr. Reddy’s Laboratories
Aurobindo Pharma
Pfizer
Amneal Pharmaceuticals
Hikma Pharmaceuticals
Allergan
GlaxoSmithKline
Among other players domestic and global, Systemic Antibiotics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Systemic Antibiotics Market Overview
1.1 Product Overview and Scope of Systemic Antibiotics
1.2 Classification of Systemic Antibiotics by Type
1.2.1 Global Systemic Antibiotics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Systemic Antibiotics Revenue Market Share by Type in 2019
1.2.3 β Lactam & β lactamase Inhibitors
1.2.4 Quinolone
1.2.5 Macrolide
1.2.6 Others
1.3 Global Systemic Antibiotics Market by Application
1.3.1 Overview: Global Systemic Antibiotics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Homecare
1.3.5 Others
1.4 Global Systemic Antibiotics Market by Regions
1.4.1 Global Systemic Antibiotics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Systemic Antibiotics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Systemic Antibiotics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Systemic Antibiotics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Systemic Antibiotics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Systemic Antibiotics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Systemic Antibiotics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bausch Health
2.1.1 Bausch Health Details
2.1.2 Bausch Health Major Business
2.1.3 Bausch Health SWOT Analysis
2.1.4 Bausch Health Product and Services
2.1.5 Bausch Health Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sun Pharmaceutical Industries
2.3.1 Sun Pharmaceutical Industries Details
2.3.2 Sun Pharmaceutical Industries Major Business
2.3.3 Sun Pharmaceutical Industries SWOT Analysis
2.3.4 Sun Pharmaceutical Industries Product and Services
2.3.5 Sun Pharmaceutical Industries Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva Pharmaceutical Industries
2.4.1 Teva Pharmaceutical Industries Details
2.4.2 Teva Pharmaceutical Industries Major Business
2.4.3 Teva Pharmaceutical Industries SWOT Analysis
2.4.4 Teva Pharmaceutical Industries Product and Services
2.4.5 Teva Pharmaceutical Industries Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan SWOT Analysis
2.5.4 Mylan Product and Services
2.5.5 Mylan Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Dr. Reddy’s Laboratories
2.6.1 Dr. Reddy’s Laboratories Details
2.6.2 Dr. Reddy’s Laboratories Major Business
2.6.3 Dr. Reddy’s Laboratories Product and Services
2.6.4 Dr. Reddy’s Laboratories Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Aurobindo Pharma
2.7.1 Aurobindo Pharma Details
2.7.2 Aurobindo Pharma Major Business
2.7.3 Aurobindo Pharma Product and Services
2.7.4 Aurobindo Pharma Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Product and Services
2.8.4 Pfizer Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amneal Pharmaceuticals
2.9.1 Amneal Pharmaceuticals Details
2.9.2 Amneal Pharmaceuticals Major Business
2.9.3 Amneal Pharmaceuticals Product and Services
2.9.4 Amneal Pharmaceuticals Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hikma Pharmaceuticals
2.10.1 Hikma Pharmaceuticals Details
2.10.2 Hikma Pharmaceuticals Major Business
2.10.3 Hikma Pharmaceuticals Product and Services
2.10.4 Hikma Pharmaceuticals Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Allergan
2.11.1 Allergan Details
2.11.2 Allergan Major Business
2.11.3 Allergan Product and Services
2.11.4 Allergan Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.12 GlaxoSmithKline
2.12.1 GlaxoSmithKline Details
2.12.2 GlaxoSmithKline Major Business
2.12.3 GlaxoSmithKline Product and Services
2.12.4 GlaxoSmithKline Systemic Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Systemic Antibiotics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Systemic Antibiotics Players Market Share
3.2.2 Top 10 Systemic Antibiotics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Systemic Antibiotics Revenue and Market Share by Regions
4.2 North America Systemic Antibiotics Revenue and Growth Rate (2015-2020)
4.3 Europe Systemic Antibiotics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Systemic Antibiotics Revenue and Growth Rate (2015-2020)
4.5 South America Systemic Antibiotics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Systemic Antibiotics Revenue and Growth Rate (2015-2020)
5 North America Systemic Antibiotics Revenue by Countries
5.1 North America Systemic Antibiotics Revenue by Countries (2015-2020)
5.2 USA Systemic Antibiotics Revenue and Growth Rate (2015-2020)
5.3 Canada Systemic Antibiotics Revenue and Growth Rate (2015-2020)
5.4 Mexico Systemic Antibiotics Revenue and Growth Rate (2015-2020)
6 Europe Systemic Antibiotics Revenue by Countries
6.1 Europe Systemic Antibiotics Revenue by Countries (2015-2020)
6.2 Germany Systemic Antibiotics Revenue and Growth Rate (2015-2020)
6.3 UK Systemic Antibiotics Revenue and Growth Rate (2015-2020)
6.4 France Systemic Antibiotics Revenue and Growth Rate (2015-2020)
6.5 Russia Systemic Antibiotics Revenue and Growth Rate (2015-2020)
6.6 Italy Systemic Antibiotics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Systemic Antibiotics Revenue by Countries
7.1 Asia-Pacific Systemic Antibiotics Revenue by Countries (2015-2020)
7.2 China Systemic Antibiotics Revenue and Growth Rate (2015-2020)
7.3 Japan Systemic Antibiotics Revenue and Growth Rate (2015-2020)
7.4 Korea Systemic Antibiotics Revenue and Growth Rate (2015-2020)
7.5 India Systemic Antibiotics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Systemic Antibiotics Revenue and Growth Rate (2015-2020)
8 South America Systemic Antibiotics Revenue by Countries
8.1 South America Systemic Antibiotics Revenue by Countries (2015-2020)
8.2 Brazil Systemic Antibiotics Revenue and Growth Rate (2015-2020)
8.3 Argentina Systemic Antibiotics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Systemic Antibiotics by Countries
9.1 Middle East & Africa Systemic Antibiotics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Systemic Antibiotics Revenue and Growth Rate (2015-2020)
9.3 UAE Systemic Antibiotics Revenue and Growth Rate (2015-2020)
9.4 Egypt Systemic Antibiotics Revenue and Growth Rate (2015-2020)
9.5 South Africa Systemic Antibiotics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Systemic Antibiotics Revenue and Market Share by Type (2015-2020)
10.2 Global Systemic Antibiotics Market Forecast by Type (2019-2024)
10.3 β Lactam & β lactamase Inhibitors Revenue Growth Rate (2015-2025)
10.4 Quinolone Revenue Growth Rate (2015-2025)
10.5 Macrolide Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Systemic Antibiotics Market Segment by Application
11.1 Global Systemic Antibiotics Revenue Market Share by Application (2015-2020)
11.2 Systemic Antibiotics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Specialty Clinic Revenue Growth (2015-2020)
11.5 Homecare Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Systemic Antibiotics Market Size Forecast (2021-2025)
12.1 Global Systemic Antibiotics Market Size Forecast (2021-2025)
12.2 Global Systemic Antibiotics Market Forecast by Regions (2021-2025)
12.3 North America Systemic Antibiotics Revenue Market Forecast (2021-2025)
12.4 Europe Systemic Antibiotics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Systemic Antibiotics Revenue Market Forecast (2021-2025)
12.6 South America Systemic Antibiotics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Systemic Antibiotics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Systemic Antibiotics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Systemic Antibiotics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Systemic Antibiotics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Systemic Antibiotics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Systemic Antibiotics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Bausch Health Corporate Information, Location and Competitors
Table 7. Bausch Health Systemic Antibiotics Major Business
Table 8. Bausch Health Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 9. Bausch Health SWOT Analysis
Table 10. Bausch Health Systemic Antibiotics Product and Solutions
Table 11. Bausch Health Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Novartis Corporate Information, Location and Competitors
Table 13. Novartis Systemic Antibiotics Major Business
Table 14. Novartis Systemic Antibiotics Total Revenue (USD Million) (2018-2019)
Table 15. Novartis SWOT Analysis
Table 16. Novartis Systemic Antibiotics Product and Solutions
Table 17. Novartis Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Sun Pharmaceutical Industries Corporate Information, Location and Competitors
Table 19. Sun Pharmaceutical Industries Systemic Antibiotics Major Business
Table 20. Sun Pharmaceutical Industries Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 21. Sun Pharmaceutical Industries SWOT Analysis
Table 22. Sun Pharmaceutical Industries Systemic Antibiotics Product and Solutions
Table 23. Sun Pharmaceutical Industries Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Teva Pharmaceutical Industries Corporate Information, Location and Competitors
Table 25. Teva Pharmaceutical Industries Systemic Antibiotics Major Business
Table 26. Teva Pharmaceutical Industries Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 27. Teva Pharmaceutical Industries SWOT Analysis
Table 28. Teva Pharmaceutical Industries Systemic Antibiotics Product and Solutions
Table 29. Teva Pharmaceutical Industries Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Mylan Corporate Information, Location and Competitors
Table 31. Mylan Systemic Antibiotics Major Business
Table 32. Mylan Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 33. Mylan SWOT Analysis
Table 34. Mylan Systemic Antibiotics Product and Solutions
Table 35. Mylan Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Dr. Reddy's Laboratories Corporate Information, Location and Competitors
Table 37. Dr. Reddy's Laboratories Systemic Antibiotics Major Business
Table 38. Dr. Reddy's Laboratories Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 39. Dr. Reddy's Laboratories SWOT Analysis
Table 40. Dr. Reddy's Laboratories Systemic Antibiotics Product and Solutions
Table 41. Dr. Reddy's Laboratories Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Aurobindo Pharma Corporate Information, Location and Competitors
Table 43. Aurobindo Pharma Systemic Antibiotics Major Business
Table 44. Aurobindo Pharma Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 45. Aurobindo Pharma SWOT Analysis
Table 46. Aurobindo Pharma Systemic Antibiotics Product and Solutions
Table 47. Aurobindo Pharma Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Pfizer Corporate Information, Location and Competitors
Table 49. Pfizer Systemic Antibiotics Major Business
Table 50. Pfizer Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 51. Pfizer SWOT Analysis
Table 52. Pfizer Systemic Antibiotics Product and Solutions
Table 53. Pfizer Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Amneal Pharmaceuticals Corporate Information, Location and Competitors
Table 55. Amneal Pharmaceuticals Systemic Antibiotics Major Business
Table 56. Amneal Pharmaceuticals Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 57. Amneal Pharmaceuticals SWOT Analysis
Table 58. Amneal Pharmaceuticals Systemic Antibiotics Product and Solutions
Table 59. Amneal Pharmaceuticals Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Hikma Pharmaceuticals Corporate Information, Location and Competitors
Table 61. Hikma Pharmaceuticals Systemic Antibiotics Major Business
Table 62. Hikma Pharmaceuticals Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 63. Hikma Pharmaceuticals SWOT Analysis
Table 64. Hikma Pharmaceuticals Systemic Antibiotics Product and Solutions
Table 65. Hikma Pharmaceuticals Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Allergan Corporate Information, Location and Competitors
Table 67. Allergan Systemic Antibiotics Major Business
Table 68. Allergan Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 69. Allergan SWOT Analysis
Table 70. Allergan Systemic Antibiotics Product and Solutions
Table 71. Allergan Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. GlaxoSmithKline Corporate Information, Location and Competitors
Table 73. GlaxoSmithKline Systemic Antibiotics Major Business
Table 74. GlaxoSmithKline Systemic Antibiotics Total Revenue (USD Million) (2017-2018)
Table 75. GlaxoSmithKline SWOT Analysis
Table 76. GlaxoSmithKline Systemic Antibiotics Product and Solutions
Table 77. GlaxoSmithKline Systemic Antibiotics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Systemic Antibiotics Revenue (Million USD) by Players (2015-2020)
Table 79. Global Systemic Antibiotics Revenue Share by Players (2015-2020)
Table 80. Global Systemic Antibiotics Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Systemic Antibiotics Revenue Market Share by Regions (2015-2020)
Table 82. North America Systemic Antibiotics Revenue by Countries (2015-2020)
Table 83. North America Systemic Antibiotics Revenue Market Share by Countries (2015-2020)
Table 84. Europe Systemic Antibiotics Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Systemic Antibiotics Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Systemic Antibiotics Revenue by Countries (2015-2020)
Table 87. South America Systemic Antibiotics Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Systemic Antibiotics Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Systemic Antibiotics Revenue Market Share by Countries (2015-2020)
Table 90. Global Systemic Antibiotics Revenue (Million USD) by Type (2015-2020)
Table 91. Global Systemic Antibiotics Revenue Share by Type (2015-2020)
Table 92. Global Systemic Antibiotics Revenue Forecast by Type (2021-2025)
Table 93. Global Systemic Antibiotics Revenue by Application (2015-2020)
Table 94. Global Systemic Antibiotics Revenue Share by Application (2015-2020)
Table 95. Global Systemic Antibiotics Revenue Forecast by Application (2021-2025)
Table 96. Global Systemic Antibiotics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Systemic Antibiotics Picture
Figure 2. Global Systemic Antibiotics Revenue Market Share by Type in 2019
Figure 3. β Lactam & β lactamase Inhibitors Picture
Figure 4. Quinolone Picture
Figure 5. Macrolide Picture
Figure 6. Others Picture
Figure 7. Systemic Antibiotics Revenue Market Share by Application in 2019
Figure 8. Hospital Picture
Figure 9. Specialty Clinic Picture
Figure 10. Homecare Picture
Figure 11. Others Picture
Figure 12. Global Systemic Antibiotics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Systemic Antibiotics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Systemic Antibiotics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Systemic Antibiotics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Systemic Antibiotics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Systemic Antibiotics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Systemic Antibiotics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Systemic Antibiotics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Systemic Antibiotics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Systemic Antibiotics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Systemic Antibiotics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Systemic Antibiotics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Systemic Antibiotics Revenue Market Share by Regions in 2018
Figure 26. North America Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 29. South America Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 31. North America Systemic Antibiotics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Systemic Antibiotics Revenue Market Share by Countries in 2019
Figure 33. USA Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Systemic Antibiotics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Systemic Antibiotics Revenue Market Share by Countries in 2019
Figure 38. Germany Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 39. UK Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 40. France Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Systemic Antibiotics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Systemic Antibiotics Revenue Market Share by Countries in 2019
Figure 45. China Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 48. India Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 50. South America Systemic Antibiotics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Systemic Antibiotics Revenue Market Share by Countries in 2019
Figure 52. Brazil Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Systemic Antibiotics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Systemic Antibiotics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Systemic Antibiotics Revenue and Growth Rate (2015-2020)
Figure 60. Global Systemic Antibiotics Revenue Share by Type (2015-2020)
Figure 61. Global Systemic Antibiotics Revenue Share by Type in 2019
Figure 62. Global Systemic Antibiotics Market Share Forecast by Type (2021-2025)
Figure 63. Global β Lactam & β lactamase Inhibitors Revenue Growth Rate (2015-2020)
Figure 64. Global Quinolone Revenue Growth Rate (2015-2020)
Figure 65. Global Macrolide Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Systemic Antibiotics Revenue Share by Application (2015-2020)
Figure 68. Global Systemic Antibiotics Revenue Share by Application in 2019
Figure 69. Global Systemic Antibiotics Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospital Revenue Growth Rate (2015-2020)
Figure 71. Global Specialty Clinic Revenue Growth Rate (2015-2020)
Figure 72. Global Homecare Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Systemic Antibiotics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Systemic Antibiotics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Systemic Antibiotics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Systemic Antibiotics Revenue Market Forecast (2021-2025)
Figure 78. Europe Systemic Antibiotics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Systemic Antibiotics Revenue Market Forecast (2021-2025)
Figure 80. South America Systemic Antibiotics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Systemic Antibiotics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Bausch Health、Novartis、Sun Pharmaceutical Industries、Teva Pharmaceutical Industries、Mylan、Dr. Reddy's Laboratories、Aurobindo Pharma、Pfizer、Amneal Pharmaceuticals、Hikma Pharmaceuticals、Allergan、GlaxoSmithKline

★調査レポート[世界の全身抗生物質市場2020年:企業別、地域別、種類・用途別] (コード:GIR20SP03940)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の全身抗生物質市場2020年:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆